Nashwan A, Abuawwad M, Jaradat J, Ibraheem A, Yassin M, Taha M
Health Sci Rep. 2024; 7(9):e2255.
PMID: 39253350
PMC: 11381317.
DOI: 10.1002/hsr2.2255.
Nogueyra S, Trujillo Rodriguez M, Garcia Oliva M, Vidal-Gallardo A, Ramirez Leal A, Beltran Hernandez J
Cureus. 2024; 16(7):e64074.
PMID: 39114232
PMC: 11305073.
DOI: 10.7759/cureus.64074.
Li D, Li J, Zhang H, Zhu Q, Wang T, Zhao W
Heliyon. 2024; 10(7):e28046.
PMID: 38560130
PMC: 10979142.
DOI: 10.1016/j.heliyon.2024.e28046.
Kurata N, Shizuku M, Jobara K, Ishizu Y, Ishigami M, Ogura Y
Case Rep Transplant. 2023; 2023:9075184.
PMID: 36968338
PMC: 10036174.
DOI: 10.1155/2023/9075184.
Valenti L, Corradini E, Adams L, Aigner E, Alqahtani S, Arrese M
Nat Rev Endocrinol. 2023; 19(5):299-310.
PMID: 36805052
PMC: 9936492.
DOI: 10.1038/s41574-023-00807-6.
Inhomogeneous liver fibrosis distribution revealed by macromolecular proton fraction quantification based on spin-lock MRI.
Qian Y, Wong V, Hou J, Jiang B, Chu W, Chen W
Quant Imaging Med Surg. 2022; 12(8):4341-4345.
PMID: 35919064
PMC: 9338361.
DOI: 10.21037/qims-22-302.
Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients.
Rostoker G, Lepeytre F, Merzoug M, Griuncelli M, Loridon C, Boulahia G
Pharmaceutics. 2022; 14(7).
PMID: 35890303
PMC: 9323124.
DOI: 10.3390/pharmaceutics14071408.
INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trial.
Majoni S, Nelson J, Germaine D, Hoppo L, Long S, Divakaran S
Trials. 2021; 22(1):868.
PMID: 34857020
PMC: 8641231.
DOI: 10.1186/s13063-021-05854-w.
Revisiting hemochromatosis: genetic phenotypic manifestations.
Anderson G, Bardou-Jacquet E
Ann Transl Med. 2021; 9(8):731.
PMID: 33987429
PMC: 8106074.
DOI: 10.21037/atm-20-5512.
Narrative Review of Hyperferritinemia, Iron Deficiency, and the Challenges of Managing Anemia in Aboriginal and Torres Strait Islander Australians With CKD.
Majoni S, Lawton P, Rathnayake G, Barzi F, Hughes J, Cass A
Kidney Int Rep. 2021; 6(2):501-512.
PMID: 33615076
PMC: 7879094.
DOI: 10.1016/j.ekir.2020.10.035.
Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility Study.
Fragkos K, Picasso Bouroncle M, Kumar S, Caselton L, Menys A, Bainbridge A
Nutrients. 2020; 12(7).
PMID: 32707726
PMC: 7400956.
DOI: 10.3390/nu12072151.
Histological Scores Validate the Accuracy of Hepatic Iron Load Measured by Signal Intensity Ratio and R2* Relaxometry MRI in Dialysis Patients.
Rostoker G, Laroudie M, Blanc R, Griuncelli M, Loridon C, Lepeytre F
J Clin Med. 2019; 9(1).
PMID: 31861625
PMC: 7019535.
DOI: 10.3390/jcm9010017.
Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations.
Rostoker G, Vaziri N
Heliyon. 2019; 5(7):e02045.
PMID: 31338466
PMC: 6627982.
DOI: 10.1016/j.heliyon.2019.e02045.
Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration.
Wilman H, Parisinos C, Atabaki-Pasdar N, Kelly M, Thomas E, Neubauer S
J Hepatol. 2019; 71(3):594-602.
PMID: 31226389
PMC: 6694204.
DOI: 10.1016/j.jhep.2019.05.032.
The influence of liver fat deposition on the quantification of the liver-iron fraction using fast-kilovolt-peak switching dual-energy CT imaging and material decomposition technique: an experimental study.
Xie T, Li Y, He G, Zhang Z, Shi Q, Cheng G
Quant Imaging Med Surg. 2019; 9(4):654-661.
PMID: 31143656
PMC: 6511718.
DOI: 10.21037/qims.2019.04.06.
Evaluation of liver tissue by ultrasound elastography and clinical parameters in children with multiple blood cell transfusions.
Wurschi G, Kentouche K, Herrmann K, Krumbein I, Nold M, Beck J
Pediatr Radiol. 2019; 49(7):897-905.
PMID: 30927037
DOI: 10.1007/s00247-019-04382-9.
Measurement of liver iron by magnetic resonance imaging in the UK Biobank population.
McKay A, Wilman H, Dennis A, Kelly M, Gyngell M, Neubauer S
PLoS One. 2018; 13(12):e0209340.
PMID: 30576354
PMC: 6303057.
DOI: 10.1371/journal.pone.0209340.
Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study.
Rostoker G, Loridon C, Griuncelli M, Rabate C, Lepeytre F, Urena-Torres P
EBioMedicine. 2018; 39:461-471.
PMID: 30502056
PMC: 6354439.
DOI: 10.1016/j.ebiom.2018.11.020.
When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?.
Rostoker G
Semin Dial. 2018; 32(1):22-29.
PMID: 29956370
PMC: 7379289.
DOI: 10.1111/sdi.12732.